RAYMED LABS Fact Sheet, RAYMED LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS Fact Sheet    (RYLB)


Act Now: Once-in-a-Century Opportunity


Here is the latest financial fact sheet of RAYMED LABS. For more details, see the RAYMED LABS quarterly results and RAYMED LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

RAYMED LABS Price History

Price Rs 1.0
Mkt Cap Rs m 4
Vol '000 0.6
P/E X -5.4
P/CF X -8.9
EPS (TTM) Rs -0.2
% ch % 4.0
No. of shares m 4.27
% ch week % 0.0
% ch 1-mth % 0.0
% ch 12-mth % -
52 week H/L Rs 1.0/0.9
(As on Nov 29, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

RAYMED LABS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
RAYMED LABS EQUITY SHARE DATA
High Rs43323 
Low Rs23221 
Sales per share (Unadj.) Rs00000 
Earnings per share (Unadj.) Rs-0.1-0.1-0.1-0.1-0.1 
Diluted earnings per shareRs-0.1-0.1-0.1-0.1-0.1 
Cash flow per share (Unadj.) Rs-0.1-0.1-0.1-0.1-0.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs-4.1-4.3-4.4-4.5-4.6 
Adj. book value per shareRs-4.1-4.3-4.4-4.5-4.6 
Shares outstanding (eoy) m4.274.274.274.274.27 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio xNMNMNMNMNM 
Avg P/E ratio x-32.5-25.1-18.8-18.1-14.8 
P/CF ratio (eoy) x-42.8-29.3-21.4-20.5-16.6 
Price / Book Value ratio x-0.7-0.7-0.6-0.5-0.4 
Dividend payout %00000 
Avg Mkt Cap Rs m121311108 
No. of employees `000NANANANANA 
Total wages/salary Rs m00000 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
RAYMED LABS INCOME DATA
Net Sales Rs m00000 
Other income Rs m00000 
Total revenues Rs m00000 
Gross profit Rs m0-1-1-1-1 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m0-1-1-1-1 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00000 
Profit after tax Rs m0-1-1-1-1 
Gross profit margin %NMNMNMNMNM 
Effective tax rate %00000 
Net profit margin %NMNMNMNMNM 
RAYMED LABS BALANCE SHEET DATA
Current assets Rs m11111 
Current liabilities Rs m2021212222 
Net working cap to sales %NMNMNMNMNM 
Current ratio x00000 
Inventory Days DaysNMNMNMNMNM 
Debtors Days DaysNMNMNMNMNM 
Net fixed assets Rs m22222 
Share capital Rs m4343434343 
"Free" reserves Rs m-60-61-61-62-63 
Net worth Rs m-18-18-19-19-20 
Long term debt Rs m00000 
Total assets Rs m33333 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x00000 
Return on assets %-13.5-18.0-21.0-20.2-21.7 
Return on equity %2.12.73.02.82.8 
Return on capital %2.12.73.02.82.8 
Exports to sales %NMNMNMNMNM 
Imports to sales %NMNMNMNMNM 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
RAYMED LABS CASH FLOW
From Operations Rs m 0 0 0 0 0 
From Investments Rs m 0 0 0 0 0 
From Financial Activity Rs m 0 0 0 0 0 
Net Cashflow Rs m 0 0 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 28.4%
Institution 1.0%
Non-Institution 70.7%
Total 100.0%
Free Float 71.6%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 103 Emperor 1, Supertech Emerald Court , Sector 93 A, Noida - 201304
E-MAIL raymedlabs@rediffmail.com WEB www.raymedlab.com
TEL 0132-3242000 FAX 0132-2664200
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Beetal Financial & Computer Services (P) Ltd, Beetal House 99 Mandangir, 3rd Floor Behind Local Shopping Centre, Near Dada Harsukhdas Mandir
YEAR OF INC: 1992 BSE CODE: 531207 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  

Compare RAYMED LABS With:   AUROBINDO PHARMA  GLENMARK PHARMA  GRANULES INDIA  LAURUS LABS   SYNGENE INTERNATIONAL  




Today's Market

Sensex Trades Lower Tracking Weak Global Cues; IT & Energy Stocks Under Pressure(10:30 am)

Asian share markets are trading mostly lower today with lingering worries over a US rate hike partly offset by potentially positive news on the severity of the Omicron coronavirus variant.

Views on news

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RAYMED LABS

RAYMED LABS - COMBAT DRUGS COMPARISON

COMPARE RAYMED LABS WITH

MARKET STATS